CIK 0001023024 · Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582301143
- Phone
- 6097591810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- 8-K Event Material agreement · New debt or obligation · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Planned sale SVP & CFO sold 2,850 shares at $72.87 ($207,680)
- 144 Insider Sale of Securities
- 4 Planned sale PRESIDENT & CEO sold 5,400 shares at $71.89 ($388,206)
- 144 Insider Sale of Securities
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 500 shares at $73.59 ($36,795)
- 4 Planned sale SVP & CFO sold 2,850 shares at $73.00 ($208,050)
- 4 Planned sale PRESIDENT & CEO sold 5,400 shares at $71.00 ($383,400)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 1,000 shares at $71.53 ($71,530)
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 500 shares at $70.79 ($35,395)
- 144 Insider Sale of Securities
- 4 Planned sale SVP & CFO sold 2,850 shares at $72.80 ($207,480)
- 4 Grant or award Director acquired 6,662 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale PRESIDENT & CEO sold 5,400 shares at $74.30 ($401,220)
- 144 Insider Sale of Securities
- 8-K Event Executive or director change
Page 1 of 90 · 1,784 filings